Evidence map›Paper›PMID 42706030›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[Alcoholic liver disease: new insights into an undeniable challenge and strategies for prevention and treatment].

C W Tang

Abstract readEnglish AbstractReview
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

C W TangLaboratory of Digestive Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term and excessive alcohol consumption is metabolized in the liver while simultaneously causing liver injury, ultimately leading to alcoholic liver disease (ALD). With the increasing consumption of alcoholic beverages among the general population, ALD has become one of the major liver diseases in China. The progression of ALD encompasses stages including hepatic steatosis, hepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. In the absence of effective pharmacotherapies for ALD, current management strategies should prioritize early diagnosis and timely reinforcement of alcohol abstinence to prevent disease progression to cirrhosis and hepatocellular carcinoma. Overlooked drinking history frequently results in missed diagnosis of ALD; therefore, greater attention should be paid to the systematic collection of long-term drinking history in clinical practice. ALD is closely associated with lifestyle factors, and its prevention and control require not only professional medical guidance and governmental public health support, but also rely on public dissemination of medical knowledge and gradual shifts in drinking culture. Furthermore, existing research achievements in ALD should be accelerated in their translation into clinical diagnostic and therapeutic strategies as well as related health industry applications, so as to promote disease prevention, early recognition, and standardized management.

Indexed as

Liver Diseases, AlcoholicHumans

Identifiers

PMID42706030
PMCPMC13529419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.